Q: Good morning 5i,
I logged on this morning (Friday) quite sure there would be a question (or five) and answer regarding MDA's recent quarter, but surprisingly not.
If the question hasn't been asked and answered by the time this one comes up, please provide your fulsome opinion on MDA's recent quarterly results and your opinion of it going forward. (I've done well by it so far, but I wonder if it's now reaching its reasonable limit based on all the factors - both tangible and not - that drive share price.)
Thanks 5i,
Peter
I logged on this morning (Friday) quite sure there would be a question (or five) and answer regarding MDA's recent quarter, but surprisingly not.
If the question hasn't been asked and answered by the time this one comes up, please provide your fulsome opinion on MDA's recent quarterly results and your opinion of it going forward. (I've done well by it so far, but I wonder if it's now reaching its reasonable limit based on all the factors - both tangible and not - that drive share price.)
Thanks 5i,
Peter
5i Research Answer:
The quarter looked good with a slight beat on revenue and a strong EPS result at $0.38 vs $0.31 expected. Backlog is strong at $4.6 bln and revenues grew 54% YoY. The company is expected to grow the top-line by 49% this year and 21% the next. We think 26X forward earnings looks reasonable here.